Scentbird puts a twist on the intimate classic that is perfume or cologne for Valentine's Day. Instead of praying that they ...

Dear readers, this time of year, my inbox fills with the same quiet sentence written a hundred different ways: “I’m tired of being the reasonable one.” It comes from the woman hosting Sunday dinner ...

NEW DELHI: In what could be good news for patients, Indian Patent Office (IPO) has rejected MNC AbbVie’s patent application for its blockbuster cancer drug Venetoclax citing lack of inventive step.

ProPublica is a nonprofit newsroom that investigates abuses of power. Sign up to receive our biggest stories as soon as they’re published. ProPublica on Friday published never-before-released data ...

The big medical news of 2026 is about the big blockbuster drug of 2025. Semaglutide (a.k.a. Ozempic, a.k.a. Wegovy) is now off patent in Canada. In the U.S. and the rest of the world, patent ...

BILOXI, Miss. (WLOX) - All West-bound lanes are blocked after Biloxi PD responded to two car crashes on I-10 at exit 44. The first crash happened just east of the exit 44 ramp. The second crash ...

Former Vice President Mike Pence called the decision "a complete betrayal of the pro-life movement that elected President Trump." Mifepristone is used in two-thirds of all abortions in the United ...

Ed Silverman, a senior writer and Pharmalot columnist at STAT, has been covering the pharmaceutical industry for nearly three decades. He is also the author of the morning Pharmalittle newsletter and ...

Federal officials have approved another generic version of the abortion pill mifepristone, a regulatory formality that quickly triggered pushback from anti-abortion groups aligned with the Trump ...

Analysts are already warning that U.S. consumers could see higher prices due to new tariffs President Donald Trump plans to impose on drug product imports as soon as next week. But a series of ...

Markets remain range-bound amid festive season optimism. Autos gain on GST & interest rate cuts, IT shows resilience despite H-1B visa updates, and pharma stays robust with generics insulated from U.S ...